"The results presented at AAO from the Phase II sub-study, the first to evaluate a gene therapy in fellow eyes for wet AMD, demonstrate that ABBV-RGX-314 could be a treatment for patients with ...

According to the American Academy of Ophthalmology (AAO) age-related macular degeneration is a leading cause of vision loss in people aged 50 and older. Besides age, risk factors for AMD include a ...